FoxP3, GATA-3 and T-bet expression in elderly asthma

Clinical and Experimental Allergy

Volumn 41, Issue 4, 2011, Pages 490-496

  Vale Pereira, S ^a,b   Todo Bom, A ^a,b,c   Geraldes, L ^b,c   Schmidt Weber, C ^b,d   Akdis, C A ^b,e   Mota Pinto, A ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Global Allergy and Asthma European Network (GA 2 LEN)   (Germany)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Aging; Asthma; FoxP3; GATA 3; Regulatory T cell; T bet

Indexed keywords

IMMUNOGLOBULIN E; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; GENE EXPRESSION REGULATION; GERIATRIC PATIENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENESCENCE; TH2 CELL;

AGED; ASTHMA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULIN E; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 79952599130     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03640.x     Document Type: Article

References (28)

1. National Institutes of Health; National Heart, Lung and Blood Institute Global Initiative for Asthma. Global strategy for asthma management and prevention. Washington, DC: National Institutes of Health; National Heart, Lung and Blood Institute, 2003 Updated 2004. NIH publication No. 02-3659. Available at (accessed 22 December 2009).
2. Kupczyk M. Long-term deterioration of lung function in asthmatic outpatients. Respiration 2004; 71:233-40.
3. Bauer BA, Reed CE, Yunginger JW, Wollan PC, Silverstein MD. Incidence and outcomes of asthma in the elderly. A population-based study in Rochester, Minnesota. Chest 1997; 111:303-10.
4. Marks GB, Poulos LM. A nationwide perspective on asthma in older Australians. Med J Aust 2005; 183 (Suppl.):S14-6.
5. Moorman JE, Rudd RA, Johnson CA et al. National surveillance for asthma - United States, 1980-2004. MMWR Surveill Summ 2007; 56:1-54.
6. + T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 2004; 113:172-8.
7. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720-45.
8. Meiler F, Zumkehr J, Klunker S, Rückert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008; 205:2887-98.
9. Bellinghausen I, Klostermann B, Knop J, Saloga J. Human CD4+CD25+T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 2003; 111:862-8.
10. Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 2009; 8:645-60.
11. + T cell subsets. J Leukoc Biol 2007; 82:335-46.
12. + T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans - impact of immunosenescence. Clin Immunol 2006; 119:307-16.
13. Seroogy CM, Gern JE. The role of T regulatory cells in asthma. J Allergy Clin Immunol 2005; 116:996-9.
14. + inducible regulatory T cells. J Exp Med 2009; 206:2701-15.
15. high regulatory T cells increases with age. Clin Exp Immunol 2005; 140:540-6.
16. Knudson R, Slavin R, Lebowitz M, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976; 113:587-600.
17. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160:2104-17.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 2001; 25:402-8.
19. Broide DH. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol 2008; 121:560-70.
20. Robinson DS. The role of the T cell in asthma. J Allergy Clin Immunol 2010, doi: DOI: 10.1016/j.jaci.2010.06.025.
21. Martinis M, Benedetto MC, Mengoli LP, Ginaldi L. Senile osteoporosis: is it an immune-mediated disease? Inflamm Res 2006; 55:399-404.
22. Ganusov VV, Pilyugin SS, Ahmed R, Antia R. How does cross-reactive stimulation affect the longevity of CD8+T cell memory? PLoS Comput Biol 2006; 2:508-17.
23. + T cells: effect of age. Exp Gerontol 2004; 39:545-50.
24. O'Shea JJ, Paul W E. Mechanisms underlying lineage commitment and plasticity of Helper CD4+T cells. Science 2010; 327:1098-102.
25. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T Cell populations. Annu Rev Immunol 2010; 28:445-89.
26. Mantel PY, Kuipers H, Boyman O et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007; 5:2847-61.
27. highT-regulatory cells in allergic asthma is subjected to TNF-α modulation. Allergy 2008; 63:67-74.
28. Provoost S, Maes T, van Durme YM et al. Decreased FOXP3 protein expression in patients with asthma. Allergy 2009; 64:1539-46.